(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.36%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
CV Sciences, Inc. operates as a life science company in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets plant-based dietary supplements and hemp-based cannabidiol (CBD) products under the PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense, and PlusCBD Pet brand names in various health care sectors, including nutraceutical, beauty care, specialty foods, and pet products...
Stats | |
---|---|
本日の出来高 | 79 205.00 |
平均出来高 | 241 460 |
時価総額 | 6.15M |
EPS | $0 ( 2024-03-27 ) |
次の収益日 | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 1.880 |
ATR14 | $0.00100 (2.66%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-03-15 | Dowling Joseph D | Buy | 2 500 000 | Employee Stock Option (right to buy) |
2023-03-15 | Grasser Joerg | Buy | 1 250 000 | Employee Stock Option (right to buy) |
2022-10-21 | Mccorkle William | Buy | 500 000 | Employee Stock Option (right to buy) |
2022-10-21 | Mccorkle William | Buy | 0 | |
2022-10-21 | Mccorkle William | Buy | 0 |
INSIDER POWER |
---|
100.00 |
Last 97 transactions |
Buy: 17 580 526 | Sell: 13 733 278 |
CV Sciences, Inc. 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
CV Sciences, Inc. 財務諸表
Annual | 2023 |
収益: | $16.00M |
総利益: | $7.09M (44.27 %) |
EPS: | $0.0201 |
FY | 2023 |
収益: | $16.00M |
総利益: | $7.09M (44.27 %) |
EPS: | $0.0201 |
FY | 2022 |
収益: | $16.21M |
総利益: | $5.55M (34.25 %) |
EPS: | $-0.0595 |
FY | 2021 |
収益: | $20.05M |
総利益: | $8.62M (42.98 %) |
EPS: | $-0.140 |
Financial Reports:
No articles found.
CV Sciences, Inc.
CV Sciences, Inc. operates as a life science company in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets plant-based dietary supplements and hemp-based cannabidiol (CBD) products under the PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense, and PlusCBD Pet brand names in various health care sectors, including nutraceutical, beauty care, specialty foods, and pet products. It sells its products through its websites, internet sales, elect distributors, brick and mortar retailers, and select e-tailers. The Specialty Pharmaceutical segment focuses on developing and commercializing cannabinoids to treat medical indications. This segment is developing drug candidate CVSI-007 that combines CBD and nicotine in treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。